Effects of edaravone in patients with acute myocardial infarction
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2008
At a glance
- Drugs Edaravone (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Feb 2008 The expected completion date for this trial is now 1 Jun 2007.
- 15 Nov 2007 Status changed from recruiting to completed.